Edgestream Partners’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.71M | Buy |
208,329
+48,057
| +30% | +$855K | 0.1% | 375 |
|
|
2025
Q1 | $2.86M | Buy |
+160,272
| New | +$2.86M | 0.1% | 388 |
|
|
2024
Q4 | – | Sell |
-115,929
| Closed | -$1.81M | – | 1020 |
|
|
2024
Q3 | $1.81M | Buy |
+115,929
| New | +$1.81M | 0.08% | 433 |
|
|
2024
Q1 | – | Sell |
-105,899
| Closed | -$1.58M | – | 963 |
|
|
2023
Q4 | $1.58M | Buy |
+105,899
| New | +$1.58M | 0.11% | 300 |
|
|
2023
Q1 | – | Sell |
-34,635
| Closed | -$2.54M | – | 622 |
|
|
2022
Q4 | $2.54M | Buy |
34,635
+20,477
| +145% | +$1.5M | 0.29% | 103 |
|
|
2022
Q3 | $1.08M | Buy |
+14,158
| New | +$1.08M | 0.08% | 267 |
|